Inventor
TOBIAS WUNBERG
Inventor
AT
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes27%
C07BGeneral methods of organic chemistry7%
PatentTitleYear
12,064,421Substituted 1H-pyrazolo[4,3-c]pyridines and derivatives as EGFR inhibitors202412,060,367Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer202412,053,473Benzylamino substituted quinazolines and derivatives as SOS1 inhibitors202411,814,380Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitors2023RE049698Substituted dihydroquinazolines2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2024Patents assigned to BOEHRINGER INGELHEIM INT (4)· patent assignee history
2023Patents assigned to AIC246 AG & CO KG (1)· patent assignee history
2023Patents assigned to AICURIS ANTI INFECTIVE CURES GMBH (1)· patent assignee history
2023–2024Based in AT· patent location history
2023Based in DE· patent location history
2024Patents assigned to UNIV VANDERBILT (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BOEHRINGER INGELHEIM INT | 4 | 2023–2024 |
| AIC246 AG & CO KG | 1 | 2023 |
| AICURIS ANTI INFECTIVE CURES GMBH | 1 | 2023 |
| UNIV VANDERBILT | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| AT | 4 | 2023–2024 |
| DE | 1 | 2023 |